As of Friday, January 09, Rigel Pharmaceuticals, Inc.’s RIGL share price has dipped by 5.01%, which has investors questioning ...
A run-up in biotech and drug stocks that sent valuations soaring through the second half of 2025 was looking a bit shaky on ...
Agios Pharma (AGIO) stock plummeted on Wednesday after the biopharmaceutical company announced the results of a Phase 3 RISE UP clinical trial. This study covered mitapivat as a treatment for sickle ...